Latest Industry News & Trends

Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.

Industry News

11/8/2024
BreakingCataractEuropeGlaucomaIndiaIndustryMeetingNewsletterRefractiveRetina
2025-2026 Ophthalmic Meetings Calendar
2025-2026 Ophthalmic Meetings Calendar

Market Scope regularly updates its list of ophthalmic meetings to keep the information current. Please contact us at matthewdouty@market-scope.com if we do not have your meeting listed. Thank you.

11/14/2024
CataractClinical TrialDealsDiagnosticDry EyeFundingGene TherapyGlaucomaIndustryInstrumentsMicroscopesNewsletterOCTPresbyopiaRegulationRetinaStudySurgical
November 2024 Ophthalmic News Briefs
November 2024 Ophthalmic News Briefs

Heidelberg Engineering announced Oct. 14 that the US FDA had granted 510(k) clearance to its Flex Module for the Spectralis diagnostic imaging platform. The Flex Module mounts the Spectralis to a m...

11/8/2024
BreakingDry EyeIndustry
Tarsus Appoints Elizabeth Yeu, MD, as Chief Medical Officer
Tarsus Appoints Elizabeth Yeu, MD, as Chief Medical Officer

Tarsus Pharmaceuticals, maker of Xdemvy for Demodex blepharitis, announced Nov. 5 that it had appointed Elizabeth Yeu, MD, as chief medical officer. Yeu had served as Tarsus’ chief medical advisor ...

10/15/2024
IndustryInstrumentsNewsletterSurgical
Zeiss Invests $24 Million to Expand Production Site in Chesterfield, Missouri
Zeiss Invests $24 Million to Expand Production Site in Chesterfield, Missouri

German company Carl Zeiss Meditec opened a new state-of-the-art research and production facility on Oct. 1 in Chesterfield, Missouri, expanding its footprint in the city, which is part of the St. L...

10/15/2024
IndustryNewsletterRetina
Harrow to Add Nearly 150 Jobs as it Expands in Nashville, Relaunches Triesence
Harrow to Add Nearly 150 Jobs as it Expands in Nashville, Relaunches Triesence

Harrow reported Sept. 25 that it is creating nearly 150 new jobs as it expands its corporate headquarters in Nashville, Tennessee. The move follows the company increasing its total leased space in ...

10/15/2024
ChinaClinical TrialDealsDiagnosticDry EyeEuropeGene TherapyGlaucomaIndiaIndustryLaserNewsletterPerimetryRegulationRetinaSurgical
October 2024 Ophthalmic News Briefs
October 2024 Ophthalmic News Briefs

Oculus has announced the addition of frequency doubling perimetry (FDP) to its Easyfield VR visual field diagnostic headset. The German ophthalmic diagnostic company, with US headquarters in Arling...

10/11/2024
BreakingGlaucomaIndustryLaserRetina
Iridex Appoints Patrick Mercer as Chief Executive Officer
Iridex Appoints Patrick Mercer as Chief Executive Officer

Iridex reported Oct. 3 that it had appointed Patrick Mercer as chief executive officer, to go along with his role as president, effective Oct. 1. Mercer had also served as the company’s chief opera...

10/11/2024
BreakingIndustryRetina
Opthea Appoints Parisa Zamiri, MD, PhD, as Chief Medical Officer
Opthea Appoints Parisa Zamiri, MD, PhD, as Chief Medical Officer

Australian drug developer Opthea announced Oct. 8 that it had appointed Parisa Zamiri, MD, PhD, as chief medical officer. Zamiri, an ophthalmologist, has clinical experience in medical retina, immu...

10/11/2024
BreakingIndustryRetina
Oak Hill Bio Promotes Josh Distler, JD, to Chief Executive Officer
Oak Hill Bio Promotes Josh Distler, JD, to Chief Executive Officer

Oak Hill Bio, of Cambridge, Massachusetts, announced Oct. 7 that it had promoted Josh Distler, JD, to chief executive officer. Distler is a co-founder of Oak Hill and previously served as the compa...

10/4/2024
BreakingIndustryInstrumentsSurgical
Zeiss Invests $24 Million to Expand Production Site in Chesterfield, Missouri
Zeiss Invests $24 Million to Expand Production Site in Chesterfield, Missouri

German company Carl Zeiss Meditec opened a new state-of-the-art research and production facility on Oct. 1 in Chesterfield, Missouri, expanding its footprint in the city, which is part of the St. L...

10/4/2024
BreakingIndustryRetina
Switzerland’s Rejuveron Life Sciences Rebrands as Centenara Labs
Switzerland’s Rejuveron Life Sciences Rebrands as Centenara Labs

Switzerland’s Rejuveron Life Sciences announced Sept. 19 that it had rebranded as Centenara Labs. The company develops and invests in therapeutic candidates to promote healthy aging. Centenara said...

10/4/2024
BreakingIndustryRetina
Eyconis Appoints Mark J. Bachleda, PharmD, MBA, as CEO
Eyconis Appoints Mark J. Bachleda, PharmD, MBA, as CEO

Eyconis announced Sept. 19 that it had appointed Mark J. Bachleda, PharmD, MBA, as chief executive officer and a member of its board of directors. Bachleda has served in executive leadership roles ...

10/4/2024
BreakingIndustryRetina
Luxa Biotechnology Appoints Keith Dionne, PhD, as CEO
Luxa Biotechnology Appoints Keith Dionne, PhD, as CEO

Luxa Biotechnology announced Oct. 1 that it had appointed Keith Dionne, PhD, as chief executive officer. Luxa, of Fort Lee, New Jersey, is advancing RPESC-RPE-4W, a cell product derived from adult ...

9/27/2024
BreakingGene TherapyIndustryRetina
AAVantgarde Bio Appoints Jayashree Sahni, MD, as Chief Medical Officer
AAVantgarde Bio Appoints Jayashree Sahni, MD, as Chief Medical Officer

Italy’s AAVantgarde Bio announced Sept. 9 that it had appointed Jayashree Sahni, MD, FRCOphth, EMBA, as chief medical officer. Sahni, a retina specialist, was senior global program clinical head at...

9/27/2024
BreakingIndustryPharma
Harrow to Add Nearly 150 Jobs as it Continues Expanding in Nashville
Harrow to Add Nearly 150 Jobs as it Continues Expanding in Nashville

Harrow reported Sept. 25 that it is creating nearly 150 new jobs as it expands its corporate headquarters in Nashville, Tennessee. The move follows the company increasing its total leased space in ...

9/19/2024
AmblyopiaClinical TrialDiagnosticFundusGene TherapyGlaucomaIndustryNewsletterRegulationRetinaSurgical
September 2024 Ophthalmic News Briefs
September 2024 Ophthalmic News Briefs

Bausch + Lomb is working with Goldman Sachs to explore a sale of the company, the Financial Times reported Sept. 14, with private equity the most likely buyer. The move is being evaluated as a way ...

9/13/2024
BreakingGlaucomaIndustryMIGSSurgical
iStar Medical Appoints Richard Beckman, MD, as Chief Medical Officer
iStar Medical Appoints Richard Beckman, MD, as Chief Medical Officer

Belgium’s iStar Medical announced Sept. 4 that it had appointed Richard Beckman, MD, as chief medical officer and member of the company’s board. Beckman most recently served as CMO of Adverum Biote...

9/13/2024
BreakingIndustryPharmaRetina
Belite Bio Appoints Hendrik P.N. Scholl, MD, MA, as Chief Medical Officer
Belite Bio Appoints Hendrik P.N. Scholl, MD, MA, as Chief Medical Officer

Belite Bio announced Sept. 1 that it had appointed Hendrik P.N. Scholl, MD, MA, as chief medical officer, effective immediately. Scholl specializes in inherited retinal and macular dystrophies, and...

9/13/2024
BreakingIndustryPharmaRetina
BioCryst Appoints Donald Fong, MD, as Chief Medical Officer
BioCryst Appoints Donald Fong, MD, as Chief Medical Officer

BioCryst Pharmaceuticals, of Durham, North Carolina, announced Sept. 5 that it had appointed Donald S. Fong, MD, MPH, as the company’s new chief medical officer, effective immediately. Fong joined ...

8/23/2024
BreakingClinical TrialIndustry
Acelyrin Shifts Pipeline to Focus on TED Candidate, Lays Off About 40 Workers
Acelyrin Shifts Pipeline to Focus on TED Candidate, Lays Off About 40 Workers

Acelyrin reported Aug. 13 that it would reduce its workforce and shift its pipeline strategy to prioritize lonigutamab, its candidate for thyroid eye disease (TED). The announcement came amid posit...

8/23/2024
BreakingGene TherapyIndustryRetina
SalioGen Therapeutics Appoints Kali Stasi, MD, PhD, as Chief Medical Officer
SalioGen Therapeutics Appoints Kali Stasi, MD, PhD, as Chief Medical Officer

SalioGen Therapeutics announced Aug. 19 that it had appointed Kalliopi “Kali” Stasi, MD, PhD, as chief medical officer. SalioGen said Stasi will be responsible for bringing the company’s SGT-1001, ...

8/21/2024
BiosimilarsCornealDealsDry EyeEuropeGene TherapyGenericsIndustryLow VisionNewsletterOcular CancerPharmaPresbyopiaRegulationRetina
August 2024 Ophthalmic News Briefs
August 2024 Ophthalmic News Briefs

Ireland-based Mallinckrodt announced Aug. 6 that its H.P. Acthar Gel single-dose prefilled SelfJect injector was available in the US. The US FDA approved the supplemental new drug application for t...

7/26/2024
BreakingCornealDealsDry EyeIndustry
Eyenovia, Senju Will Collaborate on Chronic Dry Eye Candidate with Optejet Microdoser
Eyenovia, Senju Will Collaborate on Chronic Dry Eye Candidate with Optejet Microdoser

Eyenovia, of New York, announced July 23 that it had entered into a collaboration agreement with Japan’s Senju Pharmaceutical to develop Senju’s corneal epithelial wound healing candidate, SJP-0035...

7/23/2024
IndustryMeetingNewsletter
2024 Octane Meeting Delves Into Practice Management Issues
2024 Octane Meeting Delves Into Practice Management Issues

The 2024 Octane Ophthalmology Tech Forum changed up its program from previous years, putting more focus on practice management and moving to a new location: the VEA Newport Beach, in Newport Beach,...

7/26/2024
BreakingGlaucomaIndustrySurgical
Cancer Company TME Pharma Plans to Spin Off NOX-E36 for Eye Disease
Cancer Company TME Pharma Plans to Spin Off NOX-E36 for Eye Disease

Germany’s TME Pharma, a clinical-stage cancer company, announced July 22 that it planned to spin off its asset NOX-E36 to advance it for eye disease. NOX-E36 is an L-stereoisomer RNA aptamer inhibi...

7/26/2024
BreakingGene TherapyIndustryRetina
Beacon Appoints Lance Baldo, MD, as Chief Executive Officer
Beacon Appoints Lance Baldo, MD, as Chief Executive Officer

Beacon Therapeutics announced July 24 that it had named Lance Baldo, MD, as chief executive officer, effective Aug. 12, 2024. Most recently, Baldo served as chief medical officer at Freenome, an ea...

7/23/2024
IndustryNewsletter
Market Scope Appoints Kristen Harmon Ingenito as CEO
Market Scope Appoints Kristen Harmon Ingenito as CEO

Market Scope announced July 11 that Kristen Harmon Ingenito, MBA, had been appointed chief executive officer. Dave Harmon, founder of Market Scope, will serve as chief financial officer and data se...

7/23/2024
BiosimilarsClinical TrialCornealDealsDry EyeEuropeGene TherapyGlaucomaIndiaIndustryMyopiaNewsletterRegulationRetina
July 2024 Ophthalmic News Briefs
July 2024 Ophthalmic News Briefs

Bausch + Lomb announced July 23 that it had acquired dry eye diagnostic company Trukera Medical from its private equity owner, AccelMed Partners, and other shareholders. No financial details were d...

7/19/2024
AIBreakingDiagnosticDigitalIndustry
Eyenuk Appoints Bryan Haardt as Chief Executive Officer
Eyenuk Appoints Bryan Haardt as Chief Executive Officer

Digital health care company Eyenuk, of Los Angeles, California, announced July 18 that it had appointed Bryan Haardt as chief executive officer. Paul Praino, who had been serving as Eyenuk’s interi...

7/19/2024
BreakingIndustryMyopia
Sydnexis Appoints Perry J. Sternberg as Chief Executive Officer
Sydnexis Appoints Perry J. Sternberg as Chief Executive Officer

Sydnexis, of Del Mar, California, announced July 16 that Perry J. Sternberg had been appointed chief executive officer and as a member of the board of directors. He will join the company on Aug. 5,...

7/11/2024
BreakingIndustryRetina
Alkeus Appoints Michel Dahan as President and CEO
Alkeus Appoints Michel Dahan as President and CEO

Alkeus Pharmaceuticals announced July 2 that Michel Dahan had joined the company as president and chief executive officer. He had served as a member of the board since January 2023. Alkeus, of Camb...

6/24/2024
CataractClinical TrialData SecurityDealsDiagnosticDry EyeGene TherapyGlaucomaIOLIndustryMyopiaNewsletterRefractiveRegulationRetinaSurgical
June 2024 Ophthalmic News Briefs
June 2024 Ophthalmic News Briefs

Japan’s Nidek announced June 3 that it had launched the RS-1 Glauvas OCT system. The device is CE marked as a Class IIa device. Nidek said the RS-1 Glauvas’ streamlined workflow and advanced analyt...

6/14/2024
BreakingClinical TrialGlaucomaIndustry
Skye Drops Glaucoma Program After Phase IIa Failure, Shifts Focus to Obesity
Skye Drops Glaucoma Program After Phase IIa Failure, Shifts Focus to Obesity

Skye Bioscience reported June 10 that it was discontinuing its ophthalmology program after its synthetic cannabinoid derivative SBI-100, a glaucoma drop candidate, failed to meet its Phase IIa prim...

6/14/2024
BreakingGene TherapyIndustryRetina
Regenxbio Appoints Simpson as President, CEO; Co-founder Mills Transitions to Chairman
Regenxbio Appoints Simpson as President, CEO; Co-founder Mills Transitions to Chairman

Regenxbio announced June 12 that its chief operating officer, Curran Simpson, had been appointed president and chief executive officer. He will also join the board of directors. Co-founder Kenneth ...

5/22/2024
Clinical TrialGene TherapyIOLIndustryMeetingNewsletterRetinaStudy
Ophthalmic Companies Use ARVO Meeting to Boost Research
Ophthalmic Companies Use ARVO Meeting to Boost Research

Many companies participate in ARVO’s annual meeting to catch the attention of external researchers and propel their research program or clinical trials forward. Two such companies in 2024 were John...

5/3/2024
BreakingIndustryPharmaRetina
OcuTerra to Wind Down Operations After Disappointing Phase II Results in DR
OcuTerra to Wind Down Operations After Disappointing Phase II Results in DR

OcuTerra Therapeutics, of Boston, Massachusetts, announced May 1 on LinkedIn that it would wind down operations. The company had been developing nesvategrast (OTT166 5%), an eye drop candidate for ...

5/3/2024
AIBreakingDiagnosticFundusIndustryRetina
Topcon Healthcare Appoints Ali Tafreshi as President, CEO to Lead Focus on Oculomics
Topcon Healthcare Appoints Ali Tafreshi as President, CEO to Lead Focus on Oculomics

Topcon Healthcare announced April 26 that it had appointed Ali Tafreshi as CEO and president. The company said Tafreshi will lead the company’s focus on “oculomics”—diagnosing not just eye health b...

4/24/2024
CataractDealsIndustryNewsletterPharma
Eyenovia Explores Strategic Alternatives as it Rolls Out Mydcombi, Postsurgical Steroid
Eyenovia Explores Strategic Alternatives  as it Rolls Out Mydcombi,  Postsurgical Steroid

Eyenovia reported April 8 that it is exploring strategic alternatives to maximize shareholder value, even as it rolls out Mydcombi for pupil dilation and prepares to launch its clobetasol propionat...

4/24/2024
Clinical TrialCornealData SecurityDealsDiagnosticDry EyeEnvironmentFundingGlaucomaIOLIndustryMicroscopesNewsletterRegulationRetina
April 2024 Ophthalmic News Briefs
April 2024 Ophthalmic News Briefs

Alexion, the rare disease unit of AstraZeneca, announced March 25 that the US FDA had approved its long-acting C5 complement inhibitor Ultomiris (ravulizumab-cwvz) for adults with neuromyelitis opt...

4/19/2024
BreakingIndustryPharmaRetina
Pravin Dugel, MD, Becomes President, CEO of Ocular Therapeutix
Pravin Dugel, MD, Becomes President, CEO of Ocular Therapeutix

Ocular Therapeutix announced April 15 that its executive chairman, Pravin Dugel, MD, would assume the roles of president and chief executive officer, and that Antony Mattessich is stepping down, ef...

4/12/2024
BreakingDealsIndiaIndustry
US Private Equity Firm Warburg Pincus Buys Controlling Stake in India’s Appasamy
US Private Equity Firm Warburg Pincus Buys Controlling Stake in India’s Appasamy

US-based private equity firm Warburg Pincus and Appasamy Associates announced April 10 that Warburg had bought a controlling stake in the Indian ophthalmic company. Financial details were not discl...

4/12/2024
BreakingCataractDealsIndustryPharma
Eyenovia Explores Strategic Alternatives as it Rolls Out Mydcombi, Postsurgical Steroid
Eyenovia Explores Strategic Alternatives as it Rolls Out Mydcombi, Postsurgical Steroid

Eyenovia reported April 8 that it is exploring strategic alternatives to maximize shareholder value, even as it rolls out Mydcombi for pupil dilation and prepares to launch its clobetasol propionat...

4/5/2024
BreakingDigitalIndustryMicroscopesSurgical
Beyeonics Vision Appoints A. Burton Tripathi, PhD, as CEO
Beyeonics Vision Appoints A. Burton Tripathi, PhD, as CEO

Israel’s Beyeonics Vision announced March 28 that it had appointed A. Burton Tripathi, PhD, as its new chief executive officer. Tripathi was formerly CEO of TrueVision 3D Surgical. After Alcon acqu...

4/5/2024
BreakingGlaucomaIndustryPharma
Nicox Appoints Gavin Spencer, PhD, as Chief Executive Officer
Nicox Appoints Gavin Spencer, PhD, as Chief Executive Officer

France’s Nicox announced that it had appointed Gavin Spencer, PhD, as chief executive officer, effective Feb. 28. Spencer was most recently executive vice president, chief business officer, and hea...

3/29/2024
BreakingCataractCornealIndustryRefractiveSurgical
Alcon Appoints Terry Kim, MD, as CMO, Head of Global Medical Safety
Alcon Appoints Terry Kim, MD, as CMO, Head of Global Medical Safety

Alcon announced March 26 that Terry Kim, MD, would join the company in April as chief medical officer (CMO) and head of global medical safety. Kim, who specializes in cornea, cataract, and refracti...

3/22/2024
BreakingDry EyeIndustry
Amring Adopts Name Nordic Pharma Amid Ownership Change
Amring Adopts Name Nordic Pharma Amid Ownership Change

Amring Pharmaceuticals announced March 4 that it had changed its name to Nordic Pharma Inc., following the change in ownership of the company from Sever Life Sciences to Nordic Group in June 2023. ...

3/22/2024
BreakingIndustryRetina
Clearside Biomedical Appoints Victor Chong, MD, MBA, as Chief Medical Officer
Clearside Biomedical Appoints Victor Chong, MD, MBA, as Chief Medical Officer

Clearside Biomedical announced March 18 that it had appointed Victor Chong, MD, MBA, as chief medical officer. Chong, a retina specialist, most recently served as vice president, global head of ret...

3/21/2024
CornealDealsDry EyeIOLIndustryNewsletterRegulationRetina
March 2024 Ophthalmic News Briefs
March 2024 Ophthalmic News Briefs

Germany’s VSY Biotechnology launched its Enova Maestro trifocal toric preloaded intraocular lens (IOL) at the European Society of Cataract and Refractive Surgeons (ESCRS) Winter Meeting, held Feb. ...

3/15/2024
BreakingDealsIndustry
Athyrium Takes Control of Upneeq Maker RVL Inc. as Parent Winds Down
Athyrium Takes Control of Upneeq Maker RVL Inc. as Parent Winds Down

RVL Pharmaceuticals Inc., of New Jersey, formerly a subsidiary of publicly held RVL Pharmaceuticals plc, is now owned by Athyrium Capital Management after emerging from Chapter 11 bankruptcy procee...

3/15/2024
BreakingDry EyeIndustry
Richard Lindstrom, MD, Becomes Chairman of Surface Ophthalmics
Richard Lindstrom, MD, Becomes Chairman of Surface Ophthalmics

Surface Ophthalmics, of Pleasanton, California, has named co-founder and director Richard Lindstrom, MD, as chairman. The company, which is developing dry eye drugs, was formed in 2018. Lindstrom w...

3/15/2024
BreakingCornealDry EyeIndustry
Vital Tears Appoints Joseph Tauber, MD, as Chief Medical Officer
Vital Tears Appoints Joseph Tauber, MD, as Chief Medical Officer

Vital Tears announced March 6 that it had appointed Joseph Tauber, MD, as its chief medical officer. In 2023, Vital Tears added mobile phlebotomy services to its system of providing autologous seru...

3/8/2024
BreakingIndustryRetina
EyePoint Appoints Ramiro Ribeiro, MD, PhD, as Chief Medical Officer
EyePoint Appoints Ramiro Ribeiro, MD, PhD, as Chief Medical Officer

EyePoint Pharmaceuticals announced March 4 that it had appointed retina specialist Ramiro Ribeiro, MD, PhD, as chief medical officer. Ribeiro succeeds Dario Paggiarino, MD, who had served in the ro...

3/1/2024
BreakingIndustryPharma
AbbVie Names Robert Michael to Succeed Richard Gonzalez as CEO
AbbVie Names Robert Michael to Succeed Richard Gonzalez as CEO

AbbVie reported Feb. 20 that it had named Robert A. Michael—the company’s current president and chief operating officer—to succeed Richard A. Gonzalez as chief executive officer. Michael also will ...

2/23/2024
BreakingFundingIndustryRetina
Ocular Therapeutix Announces $325 Million Private Placement, Adds Retina Specialists to Leadership Team
Ocular Therapeutix Announces $325 Million Private Placement, Adds Retina Specialists to Leadership Team

Ocular Therapeutix announced Feb. 22 that it had entered into a securities purchase agreement with institutional investors for a private placement of shares, with gross proceeds of approximately $3...

2/22/2024
ChinaDry EyeIndustryNewsletter
China’s LianBio to Wind Down Operations, Sell Off Pipeline Assets
China’s LianBio to Wind Down Operations, Sell Off Pipeline Assets

Chinese biotech company LianBio announced Feb. 13 that it would wind down operations—including selling its pipeline assets, delisting its American Depositary Shares from the Nasdaq, and cutting its...

2/22/2024
IndustryNewsletterRegulation
Eyenovia Announces US FDA Clearance of Manufacturing Facility in California
Eyenovia Announces US FDA Clearance of Manufacturing Facility in California

Eyenovia, of New York, announced Feb. 13 that the company’s facility in Redwood City, California, had successfully completed US FDA inspection for approval as a commercial manufacturing facility. T...

2/22/2024
CataractClinical TrialCornealDealsDiagnosticDry EyeGene TherapyGlaucomaIOLIndustryNewsletterPresbyopiaRegulationRetinaSurgical
February 2024 Ophthalmic News Briefs
February 2024 Ophthalmic News Briefs

Amneal Pharmaceuticals announced Jan. 10 that it had received US FDA approval for and launched generic fluorometholone eye drops. The product is indicated for the treatment of corticosteroid-respon...

2/16/2024
BreakingDry EyeIndustry
China’s LianBio to Wind Down Operations, Sell Off Pipeline Assets
China’s LianBio to Wind Down Operations, Sell Off Pipeline Assets

Chinese biotech company LianBio announced Feb. 13 that it would wind down operations—including selling its pipeline assets, delisting its American Depositary Shares from the Nasdaq, and cutting its...

2/16/2024
BreakingIndustry
Eyenovia Announces US FDA Clearance of Manufacturing Facility in Redwood City, California
Eyenovia Announces US FDA Clearance of Manufacturing Facility in Redwood City, California

Eyenovia, of New York, announced Feb. 13 that the company’s facility in Redwood City, California, had successfully completed US FDA inspection for approval as a commercial manufacturing facility. T...

2/16/2024
BreakingIndustryLaserRefractiveSurgical
Ace Vision Group Names Val Kolesnitchenko, MD, as Chief Scientific Officer
Ace Vision Group Names Val Kolesnitchenko, MD, as Chief Scientific Officer

Ace Vision Group announced Feb. 13 that it had named Val Kolesnitchenko, MD, as chief scientific officer. Most recently, Kolesnitchenko held the position of executive director of global scientific ...

2/9/2024
BreakingIndustryOptometry
Chris Throckmorton Named Chief Executive Officer of EyeCare Partners
Chris Throckmorton Named Chief Executive Officer of EyeCare Partners

EyeCare Partners, of St. Louis, Missouri, announced Jan. 25 that Chris Throckmorton had been named chief executive officer, succeeding Ben Breier, who was serving as interim CEO. The change took ef...

2/9/2024
BreakingCornealIndustry
Stuart Therapeutics Names Jodi Luchs, MD, as Chief Medical Officer
Stuart Therapeutics Names Jodi Luchs, MD, as Chief Medical Officer

Stuart Therapeutics, of Stuart, Florida, reported Feb. 1 that it had appointed Jodi Luchs, MD, as chief medical officer. Luchs is a board-certified, fellowship-trained ophthalmologist with a subspe...

2/2/2024
BreakingDiagnosticIndustry
Carl Zeiss Meditec Announces Settlement to Topcon Lawsuit Over Trade Secrets
Carl Zeiss Meditec Announces Settlement to Topcon Lawsuit Over Trade Secrets

German company Carl Zeiss Meditec, part of the Zeiss Group, reported Feb. 1 that it had settled a lawsuit it brought against Topcon Medical Systems and Topcon Healthcare Solutions, US subsidiaries ...

2/2/2024
BreakingIndustryRetina
Opthea Adds Julie Clark, MD, as Senior Vice President of Clinical Development
Opthea Adds Julie Clark, MD, as Senior Vice President of Clinical Development

Australian drug developer Opthea announced Feb. 1 the appointment of Julie Clark, MD, as senior vice president of clinical development. Clark has spent 15 years developing retinal drugs, being invo...

1/23/2024
IndustryNewsletter
2023 in Review: Surgeons and Industry Participants Select Top Story
2023 in Review: Surgeons and Industry Participants Select Top Story

Market Scope asked surgeons and industry participants to select the top story for 2023. Below are their choices. Bausch + Lomb Makes Big Moves, Adding Product Lines and Building Partnerships MAC Tu...

1/23/2024
FundingIndustryNewsletter
2023 in Review: SVB Failure Sparks Initial Panic in Ophthalmic Medtech Sector
2023 in Review: SVB Failure Sparks Initial Panic in Ophthalmic Medtech Sector

Silicon Valley Bank, of Santa Clara, California, was seized by the US government on March 11, 2023, in the second largest bank failure in US history. The failure caused a great deal of initial pani...

1/23/2024
DealsIndustryNewsletterRetina
2023 in Review: Astellas’ Deal for Iveric Bio Tops Ophthalmic Acquisitions in 2023
2023 in Review: Astellas’ Deal for Iveric Bio Tops Ophthalmic Acquisitions in 2023

Japanese drugmaker Astellas made the single largest transaction in the 2023 ophthalmic market when it acquired Iveric Bio for $5.9 billion. The deal was announced April 30 and closed on July 11, wh...

1/23/2024
IndustryNewsletterPharma
Quake in Japan Affects Some Ophthalmic Companies, News Outlet Reports
Quake in Japan Affects Some Ophthalmic Companies, News Outlet Reports

Santen Pharmaceutical, Astellas Pharma, and Nitto Medic were among Japanese ophthalmic drugmakers facing delays in manufacturing drugs in the aftermath of a massive earthquake on New Year’s Day, ne...

1/23/2024
FundingIndustryNewsletterRetina
Oxurion Avoids Bankruptcy, Will Focus on Preclinical Programs in GA
Oxurion Avoids Bankruptcy, Will Focus on Preclinical Programs in GA

Belgium’s Oxurion announced Dec. 28 that it had avoided bankruptcy through an agreement with its main creditor, Atlas Special Opportunities. Atlas will continue to fund Oxurion under an existing 20...

1/23/2024
CataractCornealDealsDry EyeGene TherapyGlaucomaIndustryLaserNewsletterOCTRegulationRetina
January 2024 Ophthalmic News Briefs
January 2024 Ophthalmic News Briefs

Maker of Sophi Phaco Machines UK-based Rayner announced Jan. 17 that it had acquired Switzerland’s This AG, the maker of Sophi phacoemulsification machines. No financial details were disclosed. Sop...

1/5/2024
BreakingDealsFundingIndustryRetina
Oxurion Avoids Bankruptcy, Will Focus on Preclinical Programs in GA
Oxurion Avoids Bankruptcy, Will Focus on Preclinical Programs in GA

Belgium’s Oxurion announced Dec. 28 that it had avoided bankruptcy through an agreement with its main creditor, Atlas Special Opportunities. Atlas will continue to fund Oxurion under an existing 20...

1/5/2024
BreakingCataractIndustrySurgical
Centricity’s Leonard Borrmann, PharmD, to Succeed Rob Thornhill as CEO
Centricity’s Leonard Borrmann, PharmD, to Succeed Rob Thornhill as CEO

Centricity Vision, of Carlsbad, California, announced Dec. 20 that Leonard Borrmann, PharmD, formerly the company’s head of research and development, had been named chief executive officer. Borrman...

1/5/2024
BreakingGene TherapyIndustryRetina
SpliceBio Appoints Aniz Girach, MD, as Chief Medical Officer
SpliceBio Appoints Aniz Girach, MD, as Chief Medical Officer

Spain’s SpliceBio announced Jan. 3 that it had appointed Aniz Girach, MD, as chief medical officer. SpliceBio’s protein splicing platform offers the potential to address diseases where the genetic ...

12/29/2023
BreakingCornealFundingIndustry
KeraLink International Launches Cornea Accelerator, Issues $100K Challenge to Innovators
KeraLink International Launches Cornea Accelerator, Issues $100K Challenge to Innovators

KeraLink International, a nonprofit group focused on eradicating global corneal blindness, announced Dec. 11 that it had launched a Cornea Technology Accelerator, open to entrepreneurs and innovato...

12/29/2023
BreakingIndustryPharmaRetina
Genentech Names Ashley Magargee as CEO
Genentech Names Ashley Magargee as CEO

Genentech, a member of the Roche Group, reported Dec. 12 that it had appointed Ashley Magargee as chief executive officer. Magargee has been serving as interim CEO since Alexander Hardy stepped dow...

12/20/2023
BreakingIndustryRetinaStudy
InMed Expands Ophthalmic Pipeline with Cannabinoid Analog INM-089 Targeting AMD
InMed Expands Ophthalmic Pipeline with Cannabinoid Analog INM-089 Targeting AMD

InMed Pharmaceuticals, of Vancouver, Canada, announced Nov. 29 that it had added to its pipeline INM-089, a cannabinoid analog, to investigate its potential treatment effect in age-related macular ...

12/15/2023
BreakingIndustryInstrumentsSurgical
Corza Opens New Development Facility in Fenton, Missouri
Corza Opens New Development Facility in Fenton, Missouri

Corza Medical reported Nov. 30 that it had opened a new Ophthalmology Center of Technology and Innovation in Fenton, Missouri, which is part of the St. Louis region. The facility, which covers 30 t...

12/14/2023
Clinical TrialIndustryNewsletterRegulationRetina
Oxurion to File for Bankruptcy After DME Candidate Misses Phase II Endpoint
Oxurion to File for Bankruptcy After DME Candidate Misses Phase II Endpoint

Belgium’s Oxurion reported Nov. 20 that it would take the steps necessary to file for bankruptcy after its plasma kallikrein inhibitor THR-149 failed to reach its primary endpoint of improvement in...

12/14/2023
IndustryInstrumentsNewsletterSurgical
Corza Opens New Development Facility in Fenton, Missouri
Corza Opens New Development Facility in Fenton, Missouri

Corza Medical reported Nov. 30 that it had opened a new Ophthalmology Center of Technology and Innovation in Fenton, Missouri, which is part of the St. Louis region. The facility, which covers 30 t...

12/14/2023
CataractClinical TrialDealsDiagnosticGene TherapyGlaucomaIndustryNewsletterRegulationRetinaTelehealth
December 2023 Ophthalmic News Briefs
December 2023 Ophthalmic News Briefs

Enzene Biosciences, based in Pune, India, announced in November that it had launched a ranibizumab biosimilar for the treatment of wet age-related macular degeneration (AMD). The product references...

12/8/2023
BreakingCataractGlaucomaIOLIndustry
SpyGlass Pharma Appoints Margot Goodkin, MD, PhD, as Chief Medical Officer
SpyGlass Pharma Appoints Margot Goodkin, MD, PhD, as Chief Medical Officer

SpyGlass Pharma announced Dec. 5 that it had appointed Margot Goodkin, MD, PhD, as chief medical officer. Goodkin is a glaucoma fellowship-trained ophthalmologist and biopharmaceutical industry vet...

12/1/2023
BreakingGene TherapyIndustryRetina
Generation Bio Drops Retinal Candidates, Cuts Workforce
Generation Bio Drops Retinal Candidates, Cuts Workforce

Generation Bio, of Cambridge, Massachusetts, reported Nov. 29 that it would stop advancing its pipeline of retinal candidates as it redefines its strategic priorities and reduces its workforce by 4...

11/22/2023
BreakingClinical TrialIndustryRetina
Oxurion to File for Bankruptcy After DME Candidate Misses Phase II Endpoint
Oxurion to File for Bankruptcy After DME Candidate Misses Phase II Endpoint

Belgium’s Oxurion reported Nov. 20 that it would take the steps necessary to file for bankruptcy after its plasma kallikrein inhibitor THR-149 failed to reach its primary endpoint of improvement in...

11/21/2023
AAOIndustryMeetingNewsletter
UCSF Ophthalmology Showcase Sends Message to Industry That It’s ‘Open for Business’
UCSF Ophthalmology Showcase Sends Message to Industry That It’s ‘Open  for Business’

The University of California, San Francisco (UCSF), held its Ophthalmology Showcase on Nov. 3 to highlight both the school’s history of ophthalmic innovation and its role in future advancements. Th...

11/21/2023
ChinaDealsDiagnosticDry EyeGene TherapyGenericsGlaucomaIndustryNewsletterPresbyopiaRegulationRetinaSurgical
November 2023 Ophthalmic News Briefs
November 2023 Ophthalmic News Briefs

Specialty pharma company Padagis announced Oct. 13 the launch of its brinzolamide ophthalmic suspension, a generic version of Novartis’ Azopt for glaucoma. Padagis, with offices in the US and Israe...

11/10/2023
BreakingGene TherapyIndustryRetina
Regenxbio Says it Will Cut Staff, Realign Pipeline Priorities to Extend Cash Runway
Regenxbio Says it Will Cut Staff, Realign Pipeline Priorities to Extend Cash Runway

Regenxbio announced in its Q3-2023 financial statement on Nov. 8 that it would cut its workforce by approximately 15 percent while prioritizing three gene therapy candidates with the largest commer...

11/10/2023
BreakingFundingGene TherapyIndustryRetina
Ascidian Raises $40 Million in Series A Funding, Appoints Michael Ehlers as Interim President, CEO
Ascidian Raises $40 Million in Series A Funding, Appoints Michael Ehlers as Interim President, CEO

Ascidian Therapeutics announced Nov. 8 that it had raised $40 million in Series A extension funding from life sciences venture capital company Apple Tree Partners. Ascidian, of Boston, Massachusett...

11/10/2023
BreakingIndustryLaserPresbyopiaRefractive
Ace Vision Group Names Rob Kissling, MD, as Chief Medical Officer
Ace Vision Group Names Rob Kissling, MD, as Chief Medical Officer

Laser company Ace Vision Group announced Nov. 1 that it had named Rob Kissling, MD, as chief medical officer. Most recently, Kissling served as vice president of clinical and medical affairs at Bau...

11/10/2023
BreakingDiagnosticIndustry
Eye Exam Kiosk Developer EyeCheq Names Ruwan Silva, MD, as Chief Medical Officer
Eye Exam Kiosk Developer EyeCheq Names Ruwan Silva, MD, as Chief Medical Officer

EyeCheq announced Nov. 2 that it had appointed Ruwan Silva, MD, as chief medical officer. Silva completed his residency in ophthalmology at Bascom Palmer Eye Institute in Miami, Florida, and his vi...

11/3/2023
BreakingIndustryPharmaRetina
Ocuphire Pharma Appoints George Magrath, MD, as Chief Executive Officer
Ocuphire Pharma Appoints George Magrath, MD, as Chief Executive Officer

Ocuphire Pharma announced Nov. 1 that it had appointed George Magrath, MD, as chief executive officer and a member of its board of directors. Magrath succeeds Rick Rodgers, interim CEO and presiden...

11/3/2023
BreakingIndustryPharmaRetina
Australia’s Opthea Appoints Fred Guerard, PharmD, as US-Based CEO
Australia’s Opthea Appoints Fred Guerard, PharmD, as US-Based CEO

Australian company Opthea announced Oct. 27 that the company’s chief executive officer, Megan Baldwin, PhD, will transition to founder and chief innovation officer, and that US-based Frederic Guera...

10/24/2023
CataractClinical TrialDealsDiagnosticDry EyeGene TherapyGenericsIOLIndustryMicroscopesNewsletterOcular CancerRegulationRetina
October 2023 Ophthalmic News Briefs
October 2023 Ophthalmic News Briefs

Théa Pharma, the US subsidiary of France’s Laboratoires Théa, announced the launch Sept. 26 of once-daily Iyuzeh (latanoprost ophthalmic solution) 0.005% in the US market. Iyuzeh is the first prese...

10/20/2023
BreakingIndustryPharma
Novartis Spins Out Sandoz, a Leading Provider of Generic Ophthalmic Drugs
Novartis Spins Out Sandoz, a Leading Provider of Generic Ophthalmic Drugs

Swiss company Novartis spun out Sandoz, its generics and biosimilars business, on Oct. 4. Sandoz is a leading provider in the US of generic ophthalmic drugs for a wide range of eye diseases. It has...

10/20/2023
BreakingDry EyeGlaucomaIndustryRegulation
Sight Sciences to Cut 25 Employees as it Awaits MACs’ Coverage Decision
Sight Sciences to Cut 25 Employees as it Awaits MACs’ Coverage Decision

Sight Sciences, of Menlo Park, California, has informed its employees that it will cut its workforce of 250 by 25 employees as it awaits a final decision by five of the seven Medicare Administrativ...

10/20/2023
BreakingIndustryRefractiveSurgical
STAAR Surgical Celebrates ICL Procedure’s 30th Anniversary
STAAR Surgical Celebrates ICL Procedure’s 30th Anniversary

STAAR Surgical reported Oct. 17 that October 2023 marked the 30th anniversary of the first implantations of the company’s Implantable Collamer Lens (ICL). The lens is intended to be implanted betwe...

10/13/2023
BreakingIndustryOptometry
Optometrists’ Lawsuit Accuses VSP Vision of Abusing its Market Power
Optometrists’ Lawsuit Accuses VSP Vision of Abusing its Market Power

Total Vision, an affiliation of 59 independent optometry practices in California, has sued VSP Vision, accusing the insurer of abusing its market power to stifle competition and pressure practices ...

10/13/2023
BreakingFundingIndustryLow Vision
Paris Court Opens Safeguard Proceedings, Similar to Bankruptcy, for Pixium Vision
Paris Court Opens Safeguard Proceedings, Similar to Bankruptcy, for Pixium Vision

France’s Pixium Vision reported Oct. 9 that the Commercial Court of Paris had opened safeguard proceedings—similar to bankruptcy protection—for the company, after Pixium said it might not be able t...

10/13/2023
BreakingCataractIOLIndustrySurgical
HumanOptics Appoints Alexander Berka as New CEO
HumanOptics Appoints Alexander Berka as New CEO

HumanOptics, of Erlangen, Germany, announced Oct. 4 that it had named Alexander Berka as its chief executive officer. HumanOptics markets an artificial iris and the Triva, Torica, and Aspria intrao...

10/13/2023
BreakingDiagnosticIndustryMicroscopes
Olaf Felske is Appointed CEO of Haag-Streit USA
Olaf Felske is Appointed CEO of Haag-Streit USA

Switzerland’s Haag-Streit Group announced Oct. 3 that it had appointed Olaf Felske as the new chief executive officer of Haag-Streit USA, its division based in Mason, Ohio. Haag-Streit USA distribu...

10/13/2023
BreakingCataractIndustrySurgical
HelpMeSee Appoints Bonnie An Henderson, MD, as President and CEO
HelpMeSee Appoints Bonnie An Henderson, MD, as President and CEO

HelpMeSee, a global nonprofit group that provides simulation training in low-cost cataract surgery, announced Oct. 10 that it had named Bonnie An Henderson, MD, as president and chief executive off...

10/6/2023
BreakingDiagnosticDigitalIndustryMicroscopesSurgical
Joseph C. Papa Joins Beyeonics Surgical as Chairman of the Board
Joseph C. Papa Joins Beyeonics Surgical as Chairman of the Board

Israel’s Beyeonics announced Oct. 4 that ophthalmic industry veteran Joseph C. Papa had joined the company as chairman of the board of Beyeonics Surgical and board member of Beyeonics Vision. Papa ...

10/6/2023
BreakingIndustryOcular CancerRetina
Aura Biosciences Appoints J. Jill Hopkins, MD, as Chief Medical Officer
Aura Biosciences Appoints J. Jill Hopkins, MD, as Chief Medical Officer

Aura Biosciences, of Boston, Massachusetts, announced Oct. 2 that it had appointed J. Jill Hopkins, MD, as chief medical officer and president of research and development. The company also announce...

9/22/2023
BreakingCataractDry EyeGlaucomaIndustryPharma
Mati Completes Facility to Manufacture Evolute Punctal Plug Portfolio
Mati Completes Facility to Manufacture Evolute Punctal Plug Portfolio

Mati Therapeutics, of Austin, Texas, reported Sept. 12 that it had completed a 10 thousand square foot facility in Bryan, Texas, to manufacture the company’s Evolute sustained drug delivery platfor...

9/22/2023
BreakingGene TherapyIndustryRetina
Nanoscope Appoints Samuel Barone, MD, as Chief Medical Officer
Nanoscope Appoints Samuel Barone, MD, as Chief Medical Officer

Nanoscope Therapeutics, of Dallas, announced Sept. 21 that it had appointed Samuel Barone, MD, as chief medical officer. Barone was most recently chief medical officer at Gemini Therapeutics, prior...

9/21/2023
ChinaClinical TrialCornealDealsDiagnosticDry EyeEuropeGene TherapyIndustryNewsletterRefractiveRegulationRetinaSurgical
September 2023 Ophthalmic News Briefs
September 2023 Ophthalmic News Briefs

Carl Zeiss Meditec announced Aug. 23 that more than 8 million eyes had been treated with the company’s SMILE procedure through the first half of 2023. SMILE, short for small-incision lenticule extr...

9/15/2023
BreakingIndustryRetina
Oxular Appoints Mark Gaffney as Chief Executive Officer
Oxular Appoints Mark Gaffney as Chief Executive Officer

UK ophthalmic company Oxular Limited announced Sept. 11 that it had appointed Mark Gaffney as chief executive officer and a member of the board of directors. Gaffney succeeds Thomas Cavanagh, who O...

9/15/2023
BreakingGlaucomaIndustryRetina
Neurotech Adds Alex Gorsky to its Board as Lead Director
Neurotech Adds Alex Gorsky to its Board as Lead Director

Neurotech Pharmaceuticals reported Sept. 13 that Alex Gorsky had been elected to its board as lead director. Gorsky, former chairman and chief executive officer of Johnson & Johnson, stepped down f...

9/1/2023
BreakingIndustryRetina
Apellis to Cut 225 Jobs, Shift R&D Priorities as it Continues Rollout of Syfovre for GA
Apellis to Cut 225 Jobs, Shift R&D Priorities as it Continues Rollout of Syfovre for GA

Apellis Pharmaceuticals, maker of the intravitreal drug Syfovre (pegcetacoplan) for geographic atrophy (GA), announced Aug. 29 that it would lay off about 225 employees—a quarter of its workforce—a...

9/1/2023
BreakingDealsGlaucomaIndustryLaserRetina
Iridex to Undergo Strategic Review
Iridex to Undergo Strategic Review

Iridex announced Aug. 29 that it would undergo a review of strategic alternatives, with Piper Sandler acting as financial advisor for the process. The Mountain View, California, ophthalmic laser co...

8/22/2023
DealsIndustryNewsletterRetina
Lurker Explains EyePoint’s Many Transitions as She Turns Over Reins
Lurker Explains EyePoint’s Many Transitions as She Turns Over Reins

Nancy Lurker, executive vice chair of EyePoint Pharmaceuticals, sat with Market Scope at the 2023 meeting of the American Society of Retina Specialists (ASRS) and reflected on the challenges of run...

8/22/2023
IndustryMeetingNewsletterRetina
OIS Retina Coaches Product Developers; Company Lineup Includes New Faces
OIS Retina Coaches Product Developers; Company Lineup Includes New Faces

Firas Rahhal, MD, moderator and co-chair of the 2023 OIS Retina meeting, said he didn’t want company pitches to focus only on their science—and most of them didn’t. “The point of pitches at OIS (fo...

8/22/2023
Gene TherapyIndustryNewsletter
Gene Therapy Developer Intergalactic Therapeutics Lays Off All Employees
Gene Therapy Developer Intergalactic Therapeutics Lays Off All Employees

Boston-headquartered Intergalactic Therapeutics has laid off all its employees and is exploring options, the Boston Business Journal reported Aug. 1. Intergalactic was developing a non-viral gene t...

8/22/2023
AICataractDealsGlaucomaIOLIndustryNewsletterPharmaRegulationRetinaSingle-Use
August 2023 Ophthalmic News Briefs
August 2023 Ophthalmic News Briefs

New York’s Icahn School of Medicine at Mount Sinai announced July 5 that it had launched the Center for Ophthalmic Artificial Intelligence and Human Health. The center will incorporate AI into educ...

8/18/2023
BreakingCataractIndustrySurgical
HelpMeSee Appoints Bonnie Henderson, MD, as Interim President and CEO
HelpMeSee Appoints Bonnie Henderson, MD, as Interim President and CEO

HelpMeSee, a global nonprofit group that provides simulation training in low-cost cataract surgery, announced Aug. 15 that it had named Bonnie Henderson, MD, as interim president and chief executiv...

8/4/2023
BreakingGene TherapyIndustryRetina
Gene Therapy Developer Intergalactic Therapeutics Lays Off All Employees
Gene Therapy Developer Intergalactic Therapeutics Lays Off All Employees

Boston-headquartered Intergalactic Therapeutics has laid off all its employees and is exploring options, the Boston Business Journal reported Aug. 1. Intergalactic was developing a non-viral gene t...

8/4/2023
BreakingGene TherapyIndustryRetina
Complement Therapeutics Appoints Parisa Zamiri, MD, PhD, as Chief Medical Officer
Complement Therapeutics Appoints Parisa Zamiri, MD, PhD, as Chief Medical Officer

Complement Therapeutics (CTx) announced Aug. 3 that it had appointed Parisa Zamiri, MD, PhD, as chief medical officer. Zamiri is an ophthalmologist by training, with clinical experience in medical ...

7/28/2023
BreakingIOLIndustry
BVI Expands IOL Manufacturing Capacity with New Facility in Belgium
BVI Expands IOL Manufacturing Capacity with New Facility in Belgium

BVI Medical announced July 18 the opening of its new, state of the art intraocular lens manufacturing facility in Liège, Belgium. The company, headquartered in Waltham, Massachusetts, said the new ...

Want to Read the Full Article?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more